Updated Date:
20 Aug 2026
Product Detail:
SPEVIGO spesolimab (rch) 450 mg in 7.5 mL concentrated solution for infusion vial
Shortage Status:
Anticipated
AUST R:
388597
Availability:
Available
Active Ingredient:
spesolimab
Reason:
Commercial Changes / Commercial viability
Dosage Form:
Injection,intravenousinfusion
Supply Impact Dates
From 01 Oct 2026
To 01 Sep 2027
Management Action:
Patients are advised to consult their healthcare professional to discuss alternative treatment options. Alternative unapproved products may be available under the Special Access Scheme (SAS). For further information about the SAS please see: https://www.tga.gov.au/form/special-access-scheme